Skip to content

13F-HR filed by Apis Capital Advisors, LLC

Apis Capital Advisors, LLC filed this 13F-HR for the quarter ended 2019-03-31, filed 2019-05-07, with 31 holding rows worth $82,909,000.

Accession
0001420506-19-000353
Filed
2019-05-07
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2019

A holdings report, 31 entries on the cover page, a total value of $82,909,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $82,909,000 with VALUE read as thousands by filing date, 13F file number 028-13123. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
AMARIN CORP PLC023111206SPONS ADR NEW1,126,700$23,390,000thousands by filing date
ARRAY BIOPHARMA INC COM04269X105Stock330,000$8,045,000thousands by filing date
ZOGENIX INC.98978L204Common Stock123,500$6,794,000thousands by filing date
KEMET CORP488360207COM NEW340,000$5,770,000thousands by filing date
GOLAR LNG LTDG9456A100SHS244,000$5,146,000thousands by filing date
VICOR CORP925815102COM120,000$3,722,000thousands by filing date
CYBEROPTICS CORP COM232517102Stock179,461$3,069,000thousands by filing date
BIOSPECIFICS TECHNOLOGIES090931106COM36,000$2,244,000thousands by filing date
INTELSAT S AL5140P101COM140,000$2,192,000thousands by filing datecall
SILICON MOTION TECHNOLOGY CORP SPONSORED ADR82706C108ADR52,900$2,097,000thousands by filing date
GREEN DOT CORP CLASS A39304D102CL A32,000$1,941,000thousands by filing date
VIKING THERAPEUTICS INC92686J106COM150,000$1,491,000thousands by filing date
CYMABAY THERAPEUTICS INC23257D103COM110,000$1,461,000thousands by filing date
VERISK ANALYTICS INC COM92345Y106Stock10,750$1,430,000thousands by filing date
AERIE PHARMACEUTICALS INC00771V108COM30,000$1,425,000thousands by filing date
MATCH GROUP INC57665R106COM25,000$1,415,000thousands by filing date
GLOBAL BLOOD THERAPEUTICS USD37890U108COM25,000$1,323,000thousands by filing date
NOVOCURE LTDG6674U108ORD SHS25,400$1,224,000thousands by filing date
DERMIRA INC24983L104COM90,000$1,220,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM10,000$1,192,000thousands by filing date
INTELSAT S AL5140P101COM70,000$1,096,000thousands by filing date
LIQTECH INTERNATIONAL53632a102COM460,000$989,000thousands by filing date
DSP GROUP INC23332B106COM69,800$982,000thousands by filing date
CONTURA ENERGY INC21241B100COM16,000$927,000thousands by filing date
CORECARD CORPORATION45816D100COM20,000$639,000thousands by filing date
TOCAGEN INC888846102COM49,374$537,000thousands by filing date
APYX MEDICAL CORPORATION03837C106COM70,000$442,000thousands by filing date
AXT INC00246W103COM70,000$312,000thousands by filing date
TURTLE BEACH CORP900450206COMMON STOCK20,000$227,000thousands by filing date
FRANCESCAS HLDGS CORP351793104COM175,000$119,000thousands by filing date
FIBROCELL SCIENCE INC315721407COM25,000$48,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001420506-19-000353this filing2019-05-07acceptance time not in the bulk data set